It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy. Competitors are nipping at its heels, cheaper alternatives have been eating into its sales, and it just gave the boot to its former CEO. Now, hoping its worst days are behind it, Novo Nordisk is offering customers a massive discount on Wegovy, the weight-loss variant of its flagship drug semaglutide, Reuters reports. For your first month of treatment, you can nab a batch of Wegovy injections for $199 until June 30, Novo Nordisk said. After that, it'll set you back $499 […]